125 related articles for article (PubMed ID: 15381449)
1. [Towards the identification of new markers of pancreatic cancer by gene expression analysis].
Rosty C
Bull Cancer; 2004; 91(7-8):593-8. PubMed ID: 15381449
[TBL] [Abstract][Full Text] [Related]
2. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications.
Rodriguez JA; Li M; Yao Q; Chen C; Fisher WE
World J Surg; 2005 Mar; 29(3):297-305. PubMed ID: 15696394
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
Argani P; Rosty C; Reiter RE; Wilentz RE; Murugesan SR; Leach SD; Ryu B; Skinner HG; Goggins M; Jaffee EM; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer Res; 2001 Jun; 61(11):4320-4. PubMed ID: 11389052
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Russo SM; Ove R; Saif MW
JOP; 2011 Mar; 12(2):92-5. PubMed ID: 21386628
[TBL] [Abstract][Full Text] [Related]
5. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration.
Chen Y; Zheng B; Robbins DH; Lewin DN; Mikhitarian K; Graham A; Rumpp L; Glenn T; Gillanders WE; Cole DJ; Lu X; Hoffman BJ; Mitas M
Int J Cancer; 2007 Apr; 120(7):1511-7. PubMed ID: 17192896
[TBL] [Abstract][Full Text] [Related]
6. S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells.
Kozono S; Ohuchida K; Ohtsuka T; Cui L; Eguchi D; Fujiwara K; Zhao M; Mizumoto K; Tanaka M
Oncol Rep; 2013 Oct; 30(4):1601-8. PubMed ID: 23900547
[TBL] [Abstract][Full Text] [Related]
7. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
[TBL] [Abstract][Full Text] [Related]
8. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.
Crnogorac-Jurcevic T; Missiaglia E; Blaveri E; Gangeswaran R; Jones M; Terris B; Costello E; Neoptolemos JP; Lemoine NR
J Pathol; 2003 Sep; 201(1):63-74. PubMed ID: 12950018
[TBL] [Abstract][Full Text] [Related]
9. Predicting novel salivary biomarkers for the detection of pancreatic cancer using biological feature-based classification.
Liu HJ; Guo YY; Li DJ
Pathol Res Pract; 2017 Apr; 213(4):394-399. PubMed ID: 28283209
[TBL] [Abstract][Full Text] [Related]
10. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
[TBL] [Abstract][Full Text] [Related]
12. Identifying molecular markers for the early detection of pancreatic neoplasia.
Goggins M
Semin Oncol; 2007 Aug; 34(4):303-10. PubMed ID: 17674958
[TBL] [Abstract][Full Text] [Related]
13. Microarray-based gene expression profiling reveals genes and pathways involved in the oncogenic function of REG3A on pancreatic cancer cells.
Xu Q; Fu R; Yin G; Liu X; Liu Y; Xiang M
Gene; 2016 Mar; 578(2):263-73. PubMed ID: 26719042
[TBL] [Abstract][Full Text] [Related]
14. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
15. Contribution of microRNA analysis to characterisation of pancreatic lesions: a review.
Visani M; Acquaviva G; Fiorino S; Bacchi Reggiani ML; Masetti M; Franceschi E; Fornelli A; Jovine E; Fabbri C; Brandes AA; Tallini G; Pession A; de Biase D
J Clin Pathol; 2015 Nov; 68(11):859-69. PubMed ID: 26314585
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel candidate oncogenes in pancreatic carcinoma using high-throughput microarrays.
Jiang Y; Liu M; Li Z; Jiang Y
Hepatogastroenterology; 2013; 60(128):1825-32. PubMed ID: 24719914
[TBL] [Abstract][Full Text] [Related]
17. Molecular versus conventional markers in pancreatic cancer.
Friess H; Kleeff J; Gumbs A; Büchler MW
Digestion; 1997; 58(6):557-63. PubMed ID: 9438602
[TBL] [Abstract][Full Text] [Related]
18. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
[TBL] [Abstract][Full Text] [Related]
19. Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.
Lee KH; Lee JK; Choi DW; Do IG; Sohn I; Jang KT; Jung SH; Heo JS; Choi SH; Lee KT
Pancreas; 2015 Jul; 44(5):764-8. PubMed ID: 25906450
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression profiling in pancreatic cancer.
López-Casas PP; López-Fernández LA
Expert Rev Mol Diagn; 2010 Jul; 10(5):591-601. PubMed ID: 20629509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
